Literature DB >> 9294932

Genetics of coxsackievirus virulence.

N M Chapman1, A I Ramsingh, S Tracy.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9294932     DOI: 10.1007/978-3-642-60687-8_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  13 in total

1.  Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.

Authors:  David V Serreze; Clive Wasserfall; Eric W Ottendorfer; Michael Stalvey; Melissa A Pierce; Charles Gauntt; Brian O'Donnell; James B Flanagan; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

3.  Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.

Authors:  Rui Gu; Cristy Stagnar; Lesya Zaichenko; Arlene I Ramsingh
Journal:  Vaccine       Date:  2012-03-29       Impact factor: 3.641

4.  Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2012-03-11       Impact factor: 3.616

5.  T cells contribute to disease severity during coxsackievirus B4 infection.

Authors:  A I Ramsingh; W T Lee; D N Collins; L E Armstrong
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis.

Authors:  Stephanie E Ostrowski; Andrew A Reilly; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon.

Authors:  M S Horwitz; T Krahl; C Fine; J Lee; N Sarvetnick
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.

Authors:  Rui Gu; Anae Shampang; Toufic Nashar; Manisha Patil; Deborah H Fuller; Arlene I Ramsingh
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

10.  Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.

Authors:  Daniel M Potvin; Dennis W Metzger; William T Lee; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.